MarketPulse

Johnson & Johnson

4 articles
Investing.comInvesting.com··Jesse Cohen

Netflix Surges While J&J Stumbles: Which Stock to Buy and Sell This Week

S&P 500 rallies 3.6% as Netflix emerges as a buy ahead of strong earnings, while J&J faces downgrades and patent cliff pressures triggering a sell recommendation.
JNJNFLXtechnical analysisNetflix
The Motley FoolThe Motley Fool··Prosper Junior Bakiny

Healthcare Giants $JNJ and $ZTS Emerge as Top Dividend Plays for 2026

Johnson & Johnson and Zoetis identified as premier dividend stocks for income investors, citing consistent growth, innovation pipelines, and demographic tailwinds.
JNJZTShealthcaredividend stocks
GlobeNewswire Inc.GlobeNewswire Inc.··Coloplast A/S

Coloplast Taps Veteran MedTech Executive Gavin Wood as New CEO

Coloplast appoints Gavin Wood as CEO effective May 2026. The veteran MedTech executive brings 20+ years from Johnson & Johnson and Mölnlycke.
CLPBYleadership transitionCEO appointment
GlobeNewswire Inc.GlobeNewswire Inc.··Coloplast A/S

Coloplast Names J&J Veteran Gavin Wood as New CEO Starting May 2026

Coloplast appoints Johnson & Johnson MedTech veteran Gavin Wood as CEO effective May 2026, replacing interim leader Lars Rasmussen.
CLPBYCEO appointmentGavin Wood